Sarah Franklin has explored the path to transbiology.  She argues that the trans-work of embryo transfer, and the translation of embryology into stem cell derivation and redirection, have altered the landscape of the biological, the technical and the informatic.  Transbiology is a biology that is made and born and is today more the norm than the exception.  In this context, it is worth reconsidering how biocapital—a form of extraction that involves isolating and mobilizing the primary reproductive agency of specific body parts, particularly cells—might be reworked with novel ethical articulations.